The GLP is committed to full transparency. Download and review our 2019 Annual Report

Realizing the promise of newborn screening

| March 19, 2013
ca d b z
Credit: Flickr/a4gpa
This article or excerpt is included in the GLP’s daily curated selection of ideologically diverse news, opinion and analysis of biotechnology innovation.

Genomics and public health have been uneasy bedfellows for some time. In a commentary in the May issue of Genetics in Medicine, James P. Evans, a geneticist and editor-in-chief of the journal, argues that it is time to start looking at genetic testing through the lens of disease prevention. By expanding the field’s focus from common to rare diseases, it may be possible to realize the promise of public health genomics by identifying millions of individuals who unknowingly carry mutations that confer a dramatic predisposition to preventable diseases.

Read the original post here: We screen newborns, don’t we?: Realizing the promise of public health genomics

Additional Reading

 

The GLP featured this article to reflect the diversity of news, opinion and analysis. The viewpoint is the author’s own. The GLP’s goal is to stimulate constructive discourse on challenging science issues.

Share via
News on human & agricultural genetics and biotechnology delivered to your inbox.
Optional. Mail on special occasions.
Send this to a friend